Clinical Trials

The Research division of the Kolschowsky Institute is dedicated to advancing medicine by connecting patients with innovative therapies that are not yet widely available. With more than 160 active clinical research trials across diverse specialties including cardiology, infectious disease, gastroenterology, neurology, oncology, pulmonology, urology, vascular health, and more. By participating in research, patients gain access to cutting edge treatment options and also play a vital role in shaping the future of healthcare. To learn more about current trials and how you can get involved, contact the Research Team.

Friday, May 29, 20260

Five Sisters Among First to Enroll in Novel Pancreatic Cancer Screening Study at Sarasota Memorial Hospital

Bound by family and driven by hope, five sisters with a family history of pancreatic cancer recently underwent a new screening test at Sarasota Memorial Hospital (SMH) to look for any pancreatic abnormalities that could later become cancer.

Tuesday, May 19, 20260

Sarasota Memorial Launches Clinical Trial to Improve Prenatal Screening for Expecting Families

Pregnant women on the Suncoast have the opportunity to take part in a global study aimed at improving prenatal screening and helping families understand their baby’s health before birth. Led locally by obstetrician-gynecologist Larry Matsumoto, MD, FACOG, of Sarasota Memorial’s First Physicians Group, in conjunction with Sarasota Memorial’s Kolschowsky Research and Education Institute.

Thursday, April 16, 20260

Sarasota Memorial Joins International Study to Prevent Atrial Fibrillation After Heart Surgery

New-onset atrial fibrillation (AFib) is one of the most common complications after heart surgery, affecting up to 50% of patients and often leading to longer hospital stays, reduced quality of life, and increased risks of stroke, heart failure and death. Researchers at Sarasota Memorial’s Kolschowsky Research and Education Institute are working to address this challenge through participation in the BoxX-NoAF clinical trial, a multicenter international study sponsored by AtriCure.

Monday, March 30, 20260

Sarasota Memorial Enrolls First Patient in Novel Clinical Trial for the Treatment of Papillary Thyroid Cancer

Sarasota Memorial Health Care System (SMH) has enrolled the first patient in a clinical study evaluating the safety and effectiveness of a novel, minimally invasive treatment for papillary thyroid cancer (PTC) using Pulse Biosciences’ nPulse™ technology.

Wednesday, March 11, 20260

Sarasota Memorial Studies Novel Pacing Approach for Heart Failure Patients

Sarasota Memorial’s Kolschowsky Research and Education Institute has joined an international clinical trial, SYNCHRONICITY, evaluating the safety and effectiveness of a new pacing approach for heart failure patients.

Tuesday, March 10, 20260

SMH research study enrolling patients with advanced skin cancer

In search of improved treatment outcomes, Sarasota Memorial’s Kolschowsky Research and Education Institute is part of an international clinical trial enrolling qualified patients with advanced stage squamous cell skin cancer, also called cutaneous squamous cell carcinoma (CSCC). It is one of the most common types of skin cancer, often found in areas exposed to the sun, such as the head, neck and arms.

Thursday, January 8, 20260

Sarasota Memorial Joins Clinical Trial for Patients with Aortic Valve Disease

The new KATALYST-AV trial, sponsored by Kardigan, Inc aims to evaluate whether the investigational medication ataciguat can slow the buildup of calcium in the aortic valve in adults with moderate calcific aortic valve stenosis (CAVS).

Wednesday, December 17, 20250

New Clinical Trials at Sarasota Memorial Explore Gene Therapy Alternative to Bladder Removal Surgery

Two new clinical trials looking at potential non-surgical options for patients with early-stage bladder cancer, known as non–muscle-invasive bladder cancer (NMIBC).

Friday, October 24, 20250

Now Enrolling Patients in Clinical Trial for Innovative AFib Treatment

Sarasota Memorial’s Kolschowsky Research and Education Institute is participating in the CONFORM Pivotal trial, evaluating a new investigational device that offers patients with AFib an alternative to long-term medication use.